Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy

Linda Gao, Karin van den Hurk, Peter T. M. Moerkerk, Jelle J. Goeman, Samuel Beck, Nelleke A. Gruis, Joost J. van den Oord, Veronique J. Winnepenninckx, Manon van Engeland, Remco van Doorn

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2957-2966
JournalJournal of Investigative Dermatology
Volume134
Issue number12
DOIs
Publication statusPublished - Dec 2014

Cite this

Gao, L., van den Hurk, K., Moerkerk, P. T. M., Goeman, J. J., Beck, S., Gruis, N. A., van den Oord, J. J., Winnepenninckx, V. J., van Engeland, M., & van Doorn, R. (2014). Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy. Journal of Investigative Dermatology, 134(12), 2957-2966. https://doi.org/10.1038/jid.2014.270